Turtle Creek Wealth Advisors LLC Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Turtle Creek Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% in the third quarter, HoldingsChannel reports. The fund owned 1,409 shares of the medical equipment provider’s stock after acquiring an additional 55 shares during the period. Turtle Creek Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $692,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Creekmur Asset Management LLC grew its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. LRI Investments LLC bought a new position in Intuitive Surgical in the 1st quarter worth about $30,000. Finally, LGT Financial Advisors LLC grew its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $10.19 during midday trading on Friday, reaching $527.61. The stock had a trading volume of 1,447,901 shares, compared to its average volume of 1,461,285. The company has a market capitalization of $187.92 billion, a price-to-earnings ratio of 84.82, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $295.02 and a 12-month high of $544.38. The stock has a 50-day moving average of $499.29 and a 200-day moving average of $457.28.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 91,178 shares of company stock valued at $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners boosted their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.